These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 34782991)

  • 1. Tailored Therapeutic Doses of Dexmedetomidine in Evolving Neuroinflammation after Traumatic Brain Injury.
    Karakaya D; Cakir-Aktas C; Uzun S; Soylemezoglu F; Mut M
    Neurocrit Care; 2022 Jun; 36(3):802-814. PubMed ID: 34782991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of Dexmedetomidine inhibited NLRP3 inflammasome and microglial cell activities in hippocampus of traumatic brain injury rats.
    Zheng B; Zhang S; Ying Y; Guo X; Li H; Xu L; Ruan X
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30232232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel small molecular NLRP3 inflammasome inhibitor alleviates neuroinflammatory response following traumatic brain injury.
    Kuwar R; Rolfe A; Di L; Xu H; He L; Jiang Y; Zhang S; Sun D
    J Neuroinflammation; 2019 Apr; 16(1):81. PubMed ID: 30975164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine reduces hippocampal microglia inflammatory response induced by surgical injury through inhibiting NLRP3.
    Peng J; Zhang P; Zheng H; Ren YQ; Yan H
    Chin J Traumatol; 2019 Jun; 22(3):161-165. PubMed ID: 31056470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury.
    Xu X; Yin D; Ren H; Gao W; Li F; Sun D; Wu Y; Zhou S; Lyu L; Yang M; Xiong J; Han L; Jiang R; Zhang J
    Neurobiol Dis; 2018 Sep; 117():15-27. PubMed ID: 29859317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NLRP3 inflammasome in traumatic brain injury: Its implication in the disease pathophysiology and potential as a therapeutic target.
    Chakraborty R; Tabassum H; Parvez S
    Life Sci; 2023 Feb; 314():121352. PubMed ID: 36592789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACT001 attenuates microglia-mediated neuroinflammation after traumatic brain injury via inhibiting AKT/NFκB/NLRP3 pathway.
    Cai L; Gong Q; Qi L; Xu T; Suo Q; Li X; Wang W; Jing Y; Yang D; Xu Z; Yuan F; Tang Y; Yang G; Ding J; Chen H; Tian H
    Cell Commun Signal; 2022 Apr; 20(1):56. PubMed ID: 35461293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine Protects Against Traumatic Brain Injury-Induced Acute Lung Injury in Mice.
    Wang Y; Wang C; Zhang D; Wang H; Bo L; Deng X
    Med Sci Monit; 2018 Jul; 24():4961-4967. PubMed ID: 30013022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine attenuated early brain injury in rats with subarachnoid haemorrhage by suppressing the inflammatory response: The TLR4/NF-κB pathway and the NLRP3 inflammasome may be involved in the mechanism.
    Yin D; Zhou S; Xu X; Gao W; Li F; Ma Y; Sun D; Wu Y; Guo Q; Liu H; Han L; Wang Z; Wang Y; Zhang J
    Brain Res; 2018 Nov; 1698():1-10. PubMed ID: 29842860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexmedetomidine inhibits inflammatory response and autophagy through the circLrp1b/miR-27a-3p/Dram2 pathway in a rat model of traumatic brain injury.
    Li H; Lu C; Yao W; Xu L; Zhou J; Zheng B
    Aging (Albany NY); 2020 Nov; 12(21):21687-21705. PubMed ID: 33147167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexmedetomidine alleviates early brain injury following traumatic brain injury by inhibiting autophagy and neuroinflammation through the ROS/Nrf2 signaling pathway.
    Feng X; Ma W; Zhu J; Jiao W; Wang Y
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglial-derived microparticles mediate neuroinflammation after traumatic brain injury.
    Kumar A; Stoica BA; Loane DJ; Yang M; Abulwerdi G; Khan N; Kumar A; Thom SR; Faden AI
    J Neuroinflammation; 2017 Mar; 14(1):47. PubMed ID: 28292310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3 polyunsaturated fatty acid attenuates the inflammatory response by modulating microglia polarization through SIRT1-mediated deacetylation of the HMGB1/NF-κB pathway following experimental traumatic brain injury.
    Chen X; Chen C; Fan S; Wu S; Yang F; Fang Z; Fu H; Li Y
    J Neuroinflammation; 2018 Apr; 15(1):116. PubMed ID: 29678169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexmedetomidine Mitigated NLRP3-Mediated Neuroinflammation
    Zhang L; Xiao F; Zhang J; Wang X; Ying J; Wei G; Chen S; Huang X; Yu W; Liu X; Zheng Q; Xu G; Yu S; Hua F
    Front Pharmacol; 2021; 12():646265. PubMed ID: 34079457
    [No Abstract]   [Full Text] [Related]  

  • 15. Dexmedetomidine Ameliorates Perioperative Neurocognitive Disorders by Suppressing Monocyte-Derived Macrophages in Mice With Preexisting Traumatic Brain Injury.
    Kii N; Sawada A; Yoshikawa Y; Tachibana S; Yamakage M
    Anesth Analg; 2022 Apr; 134(4):869-880. PubMed ID: 34319918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexmedetomidine Alters the Inflammatory Profile of Rat Microglia In Vitro.
    Scott MC; Haase CM; Olson SD; Cox CS
    Neurocrit Care; 2023 Jun; 38(3):688-697. PubMed ID: 36418766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglial Depletion with CSF1R Inhibitor During Chronic Phase of Experimental Traumatic Brain Injury Reduces Neurodegeneration and Neurological Deficits.
    Henry RJ; Ritzel RM; Barrett JP; Doran SJ; Jiao Y; Leach JB; Szeto GL; Wu J; Stoica BA; Faden AI; Loane DJ
    J Neurosci; 2020 Apr; 40(14):2960-2974. PubMed ID: 32094203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective Effects of CXCR2 Antagonist SB332235 on Traumatic Brain Injury Through Suppressing NLRP3 Inflammasome.
    Zhao K; Zhou X; Chen M; Gou L; Mei D; Gao C; Zhao S; Luo S; Wang X; Tan T; Zhang Y
    Neurochem Res; 2024 Jan; 49(1):184-198. PubMed ID: 37702890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 polyunsaturated fatty acid supplementation attenuates microglial-induced inflammation by inhibiting the HMGB1/TLR4/NF-κB pathway following experimental traumatic brain injury.
    Chen X; Wu S; Chen C; Xie B; Fang Z; Hu W; Chen J; Fu H; He H
    J Neuroinflammation; 2017 Jul; 14(1):143. PubMed ID: 28738820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target.
    O'Brien WT; Pham L; Symons GF; Monif M; Shultz SR; McDonald SJ
    J Neuroinflammation; 2020 Apr; 17(1):104. PubMed ID: 32252777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.